Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1468-1470

  Dessars, Barbara ^a   De Raeve, Linda E ^b   Housni, Hakim El ^c   Debouck, Catherine J ^c   Sidon, Pierre J ^a,d   Morandini, Renato ^d   Roseeuw, Diane ^b   Ghanem, Ghanem E ^d   Vassart, Gilbert ^a   Heimann, Pierre ^c,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CHROMOSOME 7Q; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTIC NEVUS; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN;

CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEVUS, PIGMENTED; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 34248595201     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700725     Document Type: Article

References (14)

1. Aspenström P (1997) A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol 7:479-87
2. Berg P, Lindelof B (2003) Congenital melanocytic naevi and cutaneous melanoma. Melanoma Res 13:441-5
3. Chong H, Guan KL (2003) Regulation of Raf through phosphorylation and N terminus interaction. J Biol Chem 278:36269-76
4. Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN et al. (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94-101
5. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
6. De Raeve LE, Claes A, Ruiter DJ, van Muijen GNP, Roseeuw D, van Kempen LCLT (2006) Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage. Br J Dermatol 154:485-92
7. Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H et al. (2006) High frequency of BRAF (V600E) mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 126:2111-8
8. Katoh M, Katoh M (2004) Identification and characterization of human FCHSD1 and FCHSD2 genes in silico. Int J Mol Med 13:749-54
9. Mayer BJ (2001) SH3 domains: complexity in moderation. J Cell Sci 114:1253-63
10. Mercer KE, Pritchard CA (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 1653:25-40
11. Morandini R, Boeynaems JM, Hedley SJ, MacNeil S, Ghanem G (1998) Modulation of ICAM-1 expression by ́-MSH in human melanoma cells and melanocytes. J Cell Physiol 175:276-82
12. Neves H, Ramos C, Gomes da Silva M, Parreira A, Parreira L (1999) The nuclear topography of ABL, BCR, PML, and RAŔ genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93:1197-207
13. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
14. Xiao Z, Greaves MF, Buffler P, Smith MT, Segal MR, Dicks BM et al. (2001) Molecular characterization of genomic AML1-ETO fusions in child hood leukemia. Leukemia 15:1906-13